Are you sure you'd like to remove this alert? You will no longer receive email updates about this topic.
Turkish interventional cardiology solutions firm Alvimedica is set to expand significantly its manufacturing capacity in a bid to further strengthen its position in the global heart stents and valves sectors. The company has ring-fenced around $370m to build a new facility, and its investment will be further supported by incentives from the Turkish government.
Latest From Companies
Medtech M&A activity dipped in April from last month but brought in a number of high-value acquisitions. Highlights included Fresenius, the world's largest dialysis firm, selling its majority shareholding in Sound Inpatient Physicians Holdings for $2.15bn to investment firm Summit Partners.
PureTech Health's subsidiary, Akili Interactive, has scored a $55m investment to bring its video-game therapies for treating cognitive dysfunction closer to commercialization.
Liquid biopsy company Inivata is on the hunt for a new CEO following Michael Stocum's departure.
Permira has signed a deal to acquire a majority stake in orthopedics group Corin from a group of investors for an undisclosed price.
Israel’s Ben-Gurion University (BGU) is pioneering a wave of innovation and economic progress in the Be'er-Sheva desert region. Medtech Insight meets with some of the leaders based at Ben-Gurion's Advanced Technologies Park where innovation and technology is developing the region into a world-class hi-tech hub.
Diversified medical device company Hill-Rom has appointed John Groetelaars, a senior executive from Becton Dickinson, to take over from outgoing John Greisch when the latter retires May 14.
Endovascular aortic repair specialist Endologix has promoted its COO John Onopchenko to the role of chief executive. He succeeds John McDermott, who stepped down as CEO in February following a couple of challenging years for the company.
Industry experts, investors and start-ups from across the pharma, biotech and medtech sectors gathered at the recent annual BioTrinity conference held in London to hear how the capital-raising climate is looking rosy for 2018, and to explore partnering and investment opportunities. Medtech Insight reports on predicted trends in health care and highlights two companies, Eyevensys and Rexgenero, that were presenting at the conference.
All set! This article has been sent to email@example.com.
All fields are required. For multiple recipients, separate email addresses with a semicolon.
Please Note: Only individuals with an active subscription will be able to access the full article. All other readers will be directed to the abstract and would need to subscribe.